Respira
2 known investors
Respira develops inhaled therapeutic products for pulmonary diseases, including a novel dry-powder inhalation device and lead product candidate RT234 for pulmonary arterial hypertension. The company focuses on creating drug-device combination products using advanced particle engineering and formulation technologies.
Founders & leadership
JK
John KollinsChief Executive Officer
Investors · 2
In the news
- For Monitoring COPD, Asthma, Respira Raises $2.8M for Wearable Devicecopdnewstoday.com · 2022
- Medtech Respira Labs raises $2.8M in pre-seed round - LatamListlatamlist.com · 2022
- Lung-health startup Respira Labs inhales $2.8M to help respiration patients breathe easier | TechCrunchtechcrunch.com · 2022
- Latina-Led Respira Labs Raises $2.8 Million to Revolutionize Respiratory Care for COPD, COVID-19 and Asthma Patientsfinance.yahoo.com · 2022
- Respira Labs Raises $2.8M in Pre-Seed Fundingfinsmes.com · 2022